| Literature DB >> 31653965 |
Jeany Delafiori1, Estela de Oliveira Lima2, Mohamed Ziad Dabaja1, Flávia Luísa Dias-Audibert1, Diogo Noin de Oliveira1, Carlos Fernando Odir Rodrigues Melo1, Karen Noda Morishita1, Geovana Manzan Sales1, Ana Lucia Tasca Gois Ruiz3,4, Gisele Goulart da Silva4, Marcelo Lancellotti5, Rodrigo Ramos Catharino6.
Abstract
The recent outbreak ofEntities:
Mesh:
Year: 2019 PMID: 31653965 PMCID: PMC6814752 DOI: 10.1038/s41598-019-51954-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Partial Least Square-Discriminant Analysis (PLS-DA) score plot model showing separation between PC-3 cells control (red) and PC-3 cells exposed to ZVp (green) clustering with data on positive ion mode (a) and negative ion mode (b).
Proposed chemical markers elected by PLS-DA VIP scores ≥2.2 from PC-3 prostate cancer cells exposed to Zika virus prototype on both positive and negative ion mode.
| Compound | Adduct | Experimental Mass | Theoretical Mass | Error (ppm) | ID1 | MSMS |
|---|---|---|---|---|---|---|
|
| ||||||
| PGH2-EA | [M + K]+ | 432.2505 | 432.2511 | 1.39 | 74984 | 415, 386, 372 |
| CerP(32:1)b | [M + H]+ | 590.4555 | 590.4544 | −1.86 | 103039 | 544, 309, 281, 573, 558, 232 |
| N-Acetyl-D-glucosaminyl diphosphodolichol | [M + Na]+ | 610.2145 | 610.2153 | 1.31 | 6251 | 355, 266, 464, 371, 221, 284 |
| Azelaoyl PAF | [M + H − H2O]+ | 634.4436 | 634.4448 | 1.89 | 62938 | 573, 624, 587, 520 |
| GlcCer (30:1)b | [M + H]+ | 644.5105 | 644.5096 | −1.39 | 7222 | 612,626, 598, 459, 532, 516 |
| PE(P-32:0)b | [M + H − H2O]+ | 658.5186 | 658.5176 | −1.52 | 62174a | 640, 627, 613, 459 |
| PE(P-34:4)b | [M + H − H2O]+ | 678.4872 | 678.4863 | −1.33 | 62157a | 633, 622, 660, 647, 481/482, 558, 532, 586 |
| PE-NMe(32:0)b | [M + H − H2O]+ | 688.5292 | 688.5281 | −1.59 | 40733a | 671, 566, 431/432, 641, 342, 463, 656 |
| PE(P-32:1)b | [M + H]+ | 702.5445 | 702.5432 | −1.85 | 62178a | 684, 670, 656, 333, 459, 365, 644 |
| PE(38:5)b | [M + H]+ | 766.5394 | 766.5381 | −1.70 | 60376a | 720, 706, 747, 734, 548, 569, 485 |
|
| ||||||
| HO-PGF2α or HO-PGE1c | [M + Cl]− | 405.2042 | 405.2049 | 1.73 | 36117a or 36196a | 337, 369, 387, 367, 373, 361 |
| Dihomo-PGF2α or Dihomo- PGE1 or Isoprostanesc | [M + Cl]− | 417.2408 | 417.2413 | 1.19 | 36206a or 36171a | 297, 373, 289, 399 |
| Dolichol phosphate D-mannose | [M − H]− | 425.1939 | 425.1946 | 1.64 | 5925 | 283,367, 379, 255, 313, 407 |
| PG(14:0)b | [M − H]− | 455.2421 | 455.2415 | −1.31 | 80000a | 397, 423, 339, 437, 409,387 |
| PG(12:0)b | [M + Cl]− | 477.1662 | 477.1661 | 1.87 | 4086a | 415, 459, 433, 417, 409, 441, 449 |
| PA(20:1)b | [M + Cl]− | 499.2606 | 499.2597 | −1.80 | 82345a | 383, 373, 311, 261, 431, 441, 481, 453, 463 |
| PI(12:0)b | [M − H]− | 515.2272 | 515.2263 | −1.75 | 81172 | 447, 397, 399, 401, 457, 478, 497 |
| 5-Methyltetrahydropteroy | [M − H2O − H]− | 621.2276 | 621.2269 | −1.13 | 3684 | 584, 505, 353, 563, 603, 612 |
| Isocoproporphyrin or Coproporphyrin (I, II, III or IV) c | [M − H2O − H]− | 635.2518 | 635.2506 | −1.89 | 5665a | 599, 577, 617 |
| Dehydroisocoproporphyrin | [M − H]− | 651.2471 | 651.2460 | −1.68 | 6570 | 571, 633, 615, 607, 593, 583 |
| Coproporphyrinogen (I or III)c | [M + Cl]− | 695.2863 | 695.2853 | −1.44 | 63930 or 80 | 653, 677, 665, 659, 637, 569 |
1METLIN ID; aRepresentative ID for the class; bCarbon number: double bond; cNot specified-molecules with the same m;z and similar fragmentation profile.
CerP-Ceramide phosphate; GlcCer-Glucosylceramide; PAF-Platelet activating factor; PC-Phosphatidylcholine; PE-Phosphatidylethanolamine; PI-Phosphatidylinositol; PG-Phosphatidylglycerol; HO-PGF2α-Hydroxy Prostaglandin F2α; HO-PGE1-Hydroxy Prostaglandin E1; PGH2-EA - Prostaglandin H2-Ethanolamine.
Figure 2Lipid metabolism alterations induced by ZVp on prostate cancer cells (PC-3 line) mediate increased levels of: phosphatidylinositol, a marker of ZIKV interaction with autophagic pathway (1); ceramides, that contribute to autophagy (1), mitochondrial stress (2) and membrane curvature (3); and phosphatidylethanolamine, which assist on particle recognition (4) and autophagosome formation (5). Zika virus stresses prostate cancer cells leading to high levels of ROS and consequently the presence of oxidized molecules (6) and inflammatory mediators (7). Together, all these factors may contribute to trigger cellular stress and prostate cancer cell death. Abbreviations: AA – arachidonic acid; COX – cyclooxygenase; ER – Endoplasmic reticulum; OxPL – Oxidized phospholipids; PAF – Platelet Activating Factor; PAFR – PAF receptor; PE – Phosphatidylethanolamine; PI – Phosphatidylinositol; ROS – Reactive Oxygen Species.
Figure 3Proposed interaction of ZIKV moieties with pathways involved on (a) porphyrin homeostasis, (b) protein glycosylation process and (c) one-carbon metabolism, leading to the presence of elected biomarkers (in red). (a) Heme formation is dependent of an influx of porphyrins to mitochondria which is coordinated by the action of CPOX and UROD enzymes on porphyrin precursors. However, ZIKV interaction with HO-1 enzyme (1) may interfere on heme degradation process. Disturbances on heme metabolism eventually affect porphyrins mitochondrial transport through ABCB6 (2) resulting on porphyrin accumulation (3) represented by Copn (I and II) and Dehidroisocopn and its oxidation products (4) illustrated by Cop (I, II, III and IV) and Isocop; (b) ZIKV may interact with OST complex displayed on endoplasmic reticulum (ER) (1), which has an important role on the N-glycan translocation, impairing on host cell protein glycosylation (2). This interaction may lead to misfolded protein formation (3) and ER stress (4) contributing to N-glycan precursors accumulation (5); and (c) SAM is an essential methyl donor for methylation processes and its availability impact on the one carbon metabolism molecules abundance. Possible ZIKV NS5 moieties interference on SAM (1) and SAH (2) impact SAM availability and regulation of MTHFR (3), leading to 5-MTHF accumulation (4). As consequence, 5-MTHF negatively control GNMT activity (5), decreasing sarcosine production and promoting a better prognosis to prostate cancer cells. Abbreviations: Cop – Coproporphyrin; Copn – Coproporphyrinogen; DehydroisoPn – Dehydroisocoproporphyrin; HarderoPn – Harderoporphyrinogen; Isocop – Isocoproporphyrin; Isocopn – Isocoproporphyrinogen; Ppn – Protoporphyrinogen; Pp – Protoporphyrin; Uropn – Uroporphyrinogen; CPOX – Coproporphyrinogen Oxidase; UROD – Uroporphyrinogen Decarboxylase; PPOX – Protoporphyrinogen Oxidase; FECH – Ferrochelatase; HO-1 – Heme Oxygenase; OST – Oligosaccharyltransferase; GNMT – Glycine N-Methyltransferase; 5-MTHF – 5-Methyltetrahydrofolate; THF – Tetrahydrofolate; MTHFR – Methylenetetrahydrofolate Reductase; SAM – S-Adenosylmethionine; SAH – S-Adenosylhomocysteine; MT – Methyltransferase.